A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)

Clinical trial NCT03394781 · TERMINATED

Trial details

NCT number: NCT03394781
Sponsor: Durect
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis

Start date: 2018-01-22
Primary completion: 2019-01-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.